Company Filing History:
2 out of 944 
1 out of 2 
1 out of 1 Years Active: 2006-2012
Title: **Keiya Ozawa: Innovator in Gene Transfer Technologies**
Introduction
Keiya Ozawa is a notable inventor based in Tochigi, Japan. With a total of four patents to his name, he has made significant contributions to the field of gene transfer technologies, particularly through his work with adeno-associated viral vectors.
Latest Patents
Two of his latest patents exemplify his innovative approach. The first is titled "AAV vectors produced in insect cells," which details a novel method for producing adeno-associated viral vectors in insect cells. This invention includes a unique nucleotide sequence that enhances the expression of AAV capsid proteins, thereby improving the infectivity of the viral particles. The second patent, "Gene introduction efficiency enhancer," features a histone deacetylase inhibitor as an active ingredient. This enhancer boosts gene transfer efficiency when using adeno-associated virus vectors while maintaining their beneficial traits.
Career Highlights
Throughout his career, Keiya Ozawa has been associated with reputable organizations, such as Asahi Kasei Corporation and Amsterdam Molecular Therapeutics B.V. His work in these companies has allowed him to push the boundaries of gene transfer technology and further his innovative pursuits.
Collaborations
Ozawa has collaborated with notable professionals in the field, including Takashi Okada and Akira Itoh. Their combined efforts have contributed to advancing research in gene therapy and the practical applications of adeno-associated viral vectors.
Conclusion
With four patents under his belt, Keiya Ozawa stands out as an influential inventor in gene transfer technologies. His innovative approaches not only enhance the efficacy of gene therapy but also demonstrate the potential for significant advancements in medical science. The ongoing work and collaborations of this inventor promise to yield further breakthroughs in the field.